- Investing Ideas
- /
- Swedish Healthcare High Growth Potential Companies
Swedish Healthcare High Growth Potential Companies
Results
31
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
31 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
DIGN | SEK 0.87 | -11.7% | -55.7% | SEK 70.1m | SEK 5.50 | PS0.8x | E118.7% | n/a | ||
EQL | SEK 79.80 | -4.3% | 140.4% | SEK 2.3b | SEK 65.00 | PE74.4x | E53.3% | n/a | ||
PAX | SEK 65.00 | 3.5% | 85.7% | SEK 1.2b | SEK 80.00 | PE47x | E60.8% | n/a | ||
SECT B | SEK 273.20 | -0.05% | 55.5% | SEK 52.6b | SEK 285.00 | PE136.9x | E28.5% | 0.4% | ||
CRAD B | SEK 29.75 | -3.6% | -29.0% | SEK 999.0m | SEK 49.00 | PE17.2x | E27.4% | n/a | ||
CEVI | SEK 221.00 | -2.4% | 7.0% | SEK 5.3b | SEK 270.00 | PE35.1x | E22.8% | 1.0% | ||
SYNT | SEK 27.70 | 0% | -13.4% | SEK 1.2b | SEK 30.00 | PE115.3x | E47.4% | 0% | ||
ORT B | SEK 9.28 | -0.2% | -12.0% | SEK 344.1m | SEK 20.00 | PS5.4x | E96.6% | n/a | ||
MNTC | SEK 25.00 | -4.2% | -44.1% | SEK 639.2m | SEK 42.67 | PS2.3x | E116.7% | 0% | ||
NOSA | SEK 0.92 | 27.8% | 5.0% | SEK 193.4m | SEK 0.60 | PS12.9x | E87.0% | n/a | ||
IMP A SDB | SEK 36.45 | 0.6% | 77.8% | SEK 10.3b | SEK 53.87 | PS448x | E42.5% | n/a | ||
ACARIX | SEK 0.28 | 7.8% | 48.4% | SEK 300.0m | SEK 0.45 | PS52.8x | E110.4% | n/a | ||
RAY B | SEK 204.00 | -1.7% | 127.9% | SEK 7.0b | SEK 260.00 | PE40x | E24.1% | 0.3% | ||
XVIVO | SEK 466.50 | -1.0% | 46.7% | SEK 14.7b | SEK 538.17 | PE71.9x | E23.0% | n/a | ||
ARJO B | SEK 33.96 | 0.4% | -14.8% | SEK 9.2b | SEK 41.00 | PE18.3x | E23.3% | 2.7% | ||
KONT | SEK 2.76 | -2.1% | 2.2% | SEK 88.4m | SEK 5.40 | PE89.2x | E99.6% | n/a | ||
ATT | SEK 50.90 | -3.4% | 38.1% | SEK 7.8b | SEK 61.00 | PE19.6x | E23.7% | 2.0% | ||
BOUL | SEK 8.88 | 3.3% | -12.9% | SEK 344.8m | SEK 9.50 | PS0.6x | E103.4% | 0% | ||
GETI B | SEK 174.05 | 0.4% | -22.6% | SEK 47.4b | SEK 220.78 | PE28x | E21.7% | 2.5% | ||
MEDHLP | SEK 3.06 | 3.4% | -10.0% | SEK 93.1m | n/a | PS1x | E106.0% | n/a | ||
SUS | SEK 161.50 | 5.3% | -9.3% | SEK 8.2b | SEK 192.17 | PE42.6x | E36.1% | n/a | ||
MCOV B | SEK 192.40 | 3.7% | 27.9% | SEK 28.9b | SEK 214.96 | PE127.4x | E41.8% | 0.7% | ||
EKTA B | SEK 60.30 | -4.8% | -26.1% | SEK 23.0b | SEK 73.38 | PE23x | E21.3% | 4.0% | ||
VIMIAN | SEK 42.10 | 3.8% | 49.4% | SEK 22.0b | SEK 48.03 | PE7478.5x | E89.8% | n/a |